Pfizer Inc. PFE +0.18% plans to shrink certain segments of its U.S. sales force, in the drug maker’s latest cost-cutting move.
Pfizer spokesman MacKay Jimeson said Friday the sales force would be reduced, but didn’t quantify the scope of the cuts.
“As part of our strategy to allocate our resources, investments and people to the areas that best serve our patients and customers, we continually evaluate how we can be more efficient and effective,” Mr. Jimeson said in a statement.
“As a result, we are making changes in some segments of our field force to better match the future needs of the business,” he said, adding the company remains committed to developing the field force “throughout this period of change.”
Choosen excerpts by Job Market Monitor from
via Pfizer to shrink U.S. sales force – MarketWatch.
Switzerland – Lonza to Cut Jobs
Lonza Group AG (LONN) said it plans to cut 500 jobs, including 400 at a Swiss site that manufactures chemical intermediates and active pharmaceutical ingredients. Most of the job losses will come from internal transfers, natural attrition, early retirements and by not extending temporary contracts, the Swiss supplier to the pharmaceutical industry said today in … Continue reading »
Pharmaceutical group Mylan is to create 500 jobs in Dublin and Galway
Those jobs will be created over the next five years following a €380 million investment in its Irish operations. The investment, which is being supported by IDA Ireland, will include an expansion of Mylan’s research and development (R&D) capabilities here. Mylan is the largest so-called “generics” pharmaceutical manufacturer in Ireland, producing medicines that are no … Continue reading »
UK / Novartis / Jobs may go overseas
Swiss pharmaceuticals giant Novartis has arranged a crisis meeting of scientists, NHS trustees and Government officials starting today in London in a bid to streamline Britain’s “haphazard” approach to medical research and development (R&D). Science Minister David Willetts is due to attend the meeting, thought to be the first to unite representatives of Big Pharma … Continue reading »
France – Industry Bleeds Jobs
Renault SA (RNO) says if President Francois Hollande wants more cars built in France, he needs to tackle the country’s high labor costs and rigid work rules. France’s second-largest carmaker, which is based near Paris and 15 percent owned by the government, built fewer than a quarter of the 2.83 million cars that rolled off … Continue reading »
Montreal – Pfizer cuts 300 jobs
Pharmaceutical giant Pfizer has announced it’s cutting about 300 jobs across Canada, most of them in Montreal. Julie-Catherine Racine, a spokesman for Pfizer Canada, said Sunday that the cuts will be spread across several locations but the majority will be at the company’s headquarters in the Montreal suburb of Kirkland. “After an extensive and rigorous … Continue reading »
New Jersey manufacturing needs for technical and skilled workers
Tuesday was “Student Technologic Day” at Sandvik, one event among many for the state’s first ManufactureNJ Week. The event is dedicated to improving the perception of manufacturing, generating dialogue about policies to help manufacturers and building student awareness of careers in manufacturing, said Meredith Aronson, director of the New Jersey Advanced Manufacturing Talent Network, a … Continue reading »
Ireland – GlaxoSmithKline reversing plan to close plant: 120 jobs saved
Global pharmaceutical and healthcare company GlaxoSmithKline (GSK) has reversed a decision to shut a plant run by one of its subsidiaries, saving over 100 jobs. The Stiefel facility in Co Sligo will remain open with an investment of €10m and initially retaining 120 of the 180 staff. It had been due to close next year… … Continue reading »
France – Sanofi to Cut 1500-2000 Jobs
French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources. The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said. In July, Sanofi had said it planned to cut … Continue reading »
Sweden – €4.3 million to help former AstraZeneca workers in
The European Commission has today proposed to provide Sweden with €4.3 million from the European Globalisation Adjustment Fund (EGF) to help 700 workers made redundant by the pharmaceutical firm AstraZeneca back to employment. The proposal now goes to the European Parliament and the EU’s Council of Ministers for their approval. EU Commissioner for Employment, Social … Continue reading »
Actelion Plans – 135 Jobs cut
Actelion Ltd. (ATLN) plans to cut 135 jobs and refocus research on rare diseases and specialty pharmaceuticals as sales decline for the company’s best-selling product, the Tracleer blood-pressure drug. The cost savings will reduce research spending, and some projects will be stopped, the Allschwil, Switzerland-based company said in a statement today. Actelion will take a … Continue reading »
Pingback: Pharmaceutical / The Skills Gap | Job Market Monitor - November 20, 2013